Back to Agenda
Session 4: Pharmacovigilance
Session Chair(s)
Petar Mas
Clinical pharmacology specialist
Agency for Medicinal Products and Medical Devices of the Republic of Croatia, Croatia (Hrvatska)
Sabina Polimac Šuman
Patient Safety Lead /LSR
Roche, Bosnia and Herzegovina
Izabela Majic
Chief Operating Officer, QP
IBS-Experts International d.o.o., Croatia (Hrvatska)
This session will tackle Pharmacovigilance strategies and critical role of risk minimisation measures in ensuring medicine safety. Explore the intricacies of signal detection methodologies and navigate through regulatory challenges concerning the implementation of drug traceability monitoring for enhanced patient care and regulatory compliance in Bosnia and Herzegovina.
Speaker(s)
Pharmacovigilance in Serbia: Opportunities and Challenges
Marko Eric
Medicines and Medical Devices Agency of Serbia , Serbia
Pharmacovigilance Assessor
Regulatory Challenges in the Implementation of Drug Traceability Monitoring in Bosnia and Herzegovina
Azira Cajic
ALMBiH, Bosnia and Herzegovina
Head of Pharmacovigilance and Materiovigilance Sector
Risk Minimisation Measures: which and when?
Barbara Kovacic Bytyqi
Agency for Medicinal Products And Medical Devices of Croatia (HALMED), Croatia (Hrvatska)
Head of Pharmacovigilance and Rational Pharmacotherapy Department
Project Smart Pharmacist – The Importance of Education in Pharmacovigilance
Svetlana Vujovic
CInMED, Montenegro
With Additional Participation of:
Marijana Danevska
Macedonian Agency for Medicines and Medical Equipment (MALMED), North Macedonia
Have an account?